Contact Information
Company Information
Professional Summary
Elad Bibi-Aviv serves as COO/CRO at Genetika+. Genetika+ operates in the research sector with approximately 44.0 employees. The company is headquartered in Tel Aviv-Yafo, Tel Aviv District. To date, Genetika+ has raised 20000000.0 in total funding, with the most recent round being Series A.
Industry & Role Insights
-
•
MessageCEO tracks 2,961 executives in the research sector.
-
•
We have verified contacts for 2 executives at Genetika+.
-
•
443 executive contacts are available in Tel Aviv District.
-
•
Our database includes 201,469 c suite-level executives.
Technologies
Gmail
Google Apps
Amazon AWS
Hubspot
Mobile Friendly
Google Tag Manager
Vimeo
Wix
Google Analytics
YouTube
Varnish
Google Font API
Remote
Keywords
biotechnology
neuroscience
mental illness
ww
biotechnology research
precision medicine
psychiatry
neurology
ai
stem cell technology
digital health
patient-derived neurons
biobanking
drug discovery
clinical data
cns diseases
neural differentiation
drug response prediction
biomarkers
patient stratification
evidence-based care
personalized treatment
computer vision
machine learning
bioinformatics
pharmaceutical collaborations
clinical trials
depression treatment
mental health
drug development
targeted therapies
proprietary platform
ipsc
neurobiology
mental health disorders
neuroplasticity
clinical phenotyping
antidepressant matching
neuroinformatics
research partnerships
drug efficacy
multimodal data
rna transcript analysis
exposure response models
treatment optimization
genomic analysis
clinical insights
data repository
patient-centered care
emerging therapies
subgroup analysis
health
wellness & fitness
information technology & services
artificial intelligence
health care
hospital & health care
Related Executives
Outreach Guidance — research Sector
Executives like Elad Bibi-Aviv in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Genetika+.
Elad Bibi-Aviv's Position in the MessageCEO Database
- •Elad Bibi-Aviv is 1 of 2 verified executive contacts we track at Genetika+.
- •2,871 verified executive contacts in research are in the MessageCEO database.
- •441 verified executive contacts in Tel Aviv District are in the database.
- •26 verified contacts work at research companies in the 44.0 employee range (same size as Genetika+).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Frequently Asked Questions
How do I reach Elad Bibi-Aviv directly?
Elad Bibi-Aviv's verified email address is available to MessageCEO Pro subscribers. They currently serve as COO/CRO at Genetika+. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Elad Bibi-Aviv work for?
Elad Bibi-Aviv is COO/CRO at Genetika+, a company in the research sector with 44.0 employees. The company is based in Tel Aviv-Yafo, Tel Aviv District.
Can I pitch or sell to Elad Bibi-Aviv?
As COO/CRO at Genetika+, Elad Bibi-Aviv is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Elad Bibi-Aviv directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Elad Bibi-Aviv in?
Elad Bibi-Aviv works in the research industry as COO/CRO at Genetika+. MessageCEO provides verified contact information for executives across all major industries.
Is Elad Bibi-Aviv's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Elad Bibi-Aviv's profile is kept up-to-date with the latest available information.
Last updated: July 22, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans